!!Look Patients!!

Our new medication is so cutting edge and advanced that one of the largest pharmaceutical companies, Johnson and Johnson, got approval from the FDA for a similar product with exactly the same mechanism.

FDA Approves Johnson & Johnson’s (JNJ) Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain.

 Tapentadol (like our Neurocet) works in two ways - it boosts available levels of the neurotransmitter norepinephrine (which tends to be low in people with chronic pain) and also contains an opiate, like Vicodin (hydrocodone) and OxyContin (oxycodone).

In their clinical studies, patients with low back pain or pain from osteoarthritis of the knee or hip were treated with a flexible dose of 50 mg or 100 mg of Tapentadol  every four to six hours, up to a maximum of 600 mg/day, or a flexible dose of 10 mg or 15 mg of Oxycodone  every four to six hours, up to a maximum of 90 mg/day; patients were treated for up to 90 days. While both tapentadol IR and oxycodone IR offered equal pain relief, the Tapentadol  treatment group experienced a statistically significantly lower incidence of nausea, vomiting, constipation and withdrawals for all treatment comparisons.

RARITAN, N.J., November 21, 2008 /PRNewswire -- Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), announced that the U.S. Food and Drug Administration (FDA) approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults 18 years of age or older.

Tapentadol is a new centrally acting oral analgesic. It has two mechanisms of action, combining mu-opioid receptor agonism and norepinephrine reuptake inhibition.

Mu-opioid agonists (like Tramadol) are drugs that bind to and activate mu-opioid receptors in the central nervous system. These drugs modify sensory and affective aspects of pain, inhibit the transmission of pain at the spinal cord and effect the activity at parts of the brain that control how pain is perceived. Norepinephrine reuptake inhibitors (like Nortriptyline) are a type of central nervous system medication that increases the level of norepinephrine in the brain by inhibiting its re-absorption into nerve cells.These compounds have strong analgesic (pain relieving) properties.

 See The Neurocet versus Hydrocodone Multicenter Meta-Analysis Study

Benefits-as shown through multiple research studies:

-Extremely effective pain control and exceptionally well tolerated

-The combination has been researched and proven extensively in the medical literature and clinical studies

-Has significantly helped patients with one of the most debilitating pain-Diabetic Peripheral Neuropathy and post surgical pain

-Significant reduction in withdrawal symptoms when coming off hydrocodone and opiods

-A safe, legal and non-narcotic pain medication alternative

-Beneficial in relieving depressive/anxiety symptoms associated with pain and withdrawal

-No significant addiction or dependency potential

-Improved sleep with muscle relaxation

-Markedly improved daily functioning

-Greater energy and exercise capacity

-No tendency for blood pressure elevation, fatigue, sedation or constipation as with hydrocodone or codeine

-Absolutely no delays in shipping and supply

-FDA Approved Ingredients

Please click below to:

Request Consultation

To ask any questions about our new medication-click below to:

Ask Our Medical Director

Dr. Raza

Please, continue to update us with yearly medical records/physical exams and weekly reliefinsite.com pain/symptom diary.

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008

Was signed by George W. Bush on Oct. 15^th, 2008. The act states: Federal law now requires that you must have an in-person (face-to-face) medical evaluation with the prescribing physician who will verify and document your current condition for which you are receiving or requesting treatment for. It will be illegal for any patient to obtain and any physician to prescribe controlled medications via the internet. There are no exceptions to this rule. All patients will be required to be seen in-office for a complete physical exam and medical evaluations before being prescribed any controlled medication(s).   MedsNationwide will be in strict compliance with the provisions of this new and important law which the doctors and staff of MedsNationwide strongly support. In anticipation of this law, the board certified physicians of MedsNationwide  , along with highly respected pain physician scientists/researchers, have diligently worked on and researched a safe, effective, non-narcotic/non-controlled alternative for your chronic pain and associated symptoms. Please, visit our website periodically as we are about to unveil this new and exciting non-narcotic alternative for our patients!!!  MedsNationwide understands the need for effective pain control to facilitate activities of daily living, proper physical function at home and work and greatly reducing the withdrawal symptoms associated with tapering off narcotic analgesics. We have always put your health and safety first and we believe this law and research endeavor further enhances such a mission by protecting our patients and community by enacting stricter controls over internet prescribing practices and providing a safe and legal pain medication alternative. All patients who choose to use MedsNationwide will be required to comply with this new law  immediately. The following is a summary of The Ryan Haight Act of 2008 with important points highlighted in red and blue:

       S 980 ESRFH

110th CONGRESS

2d Session

S. 980

??

IN THE HOUSE OF REPRESENTATIVES

April 2, 2008

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

AN ACT

To amend the Controlled Substances Act to address online pharmacies.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the:

`Ryan Haight Online Pharmacy Consumer Protection Act of 2008'.

SEC. 2. REQUIREMENT OF A VALID PRESCRIPTION FOR CONTROLLED SUBSTANCES DISPENSED BY MEANS OF THE INTERNET.

Section 309 of the Controlled Substances Act (21 U.S.C. 829) is amended by adding at the end the following:

`(e) Controlled Substances Dispensed by Means of the Internet-

`(1) No controlled substance may be delivered, distributed, or dispensed by means of the Internet without a valid prescription.

`(2) As used in this subsection:

`(A) The term `valid prescription' means a prescription that is issued for a legitimate medical purpose in the usual course of professional practice by--

`(i) a practitioner who has conducted at least 1 in-person medical evaluation of the patient; or

`(ii) a covering practitioner.

`(B)(i) The term `in-person medical evaluation' means a medical evaluation that is conducted with the patient in the physical presence of the practitioner, without regard to whether portions of the evaluation are conducted by other health professionals.

 To view the entire and detailed Ryan Haight Act of 2008 copy and paste the following address into your browser: http://www.govtrack.us/congress/billtext.xpd?bill=h110-6353.

Since Soma (carisprodol) is a controlled medication in the following states-it cannot be prescribed to patients residing in those states.

Alabama, Arizona, Georgia, Hawaii, Florida, Kentucky, Massachusetts, Nevada, New Mexico, Oklahoma